Purchase Order 75N92E19P00175

<p>The National Human Genome Research Institute awarded a purchase order to Partek, Incorporated for $9,330.00 on May 2, 2018, with completion targeted for June 1, 2019. No set-aside applies. Performance occurs in Bethesda, Maryland. The order procures bioinformatics software solutions, specifically genomic analysis and visualization tools for federal research. Pricing is firm fixed price.</p>

Partek, Inc. was awarded an $83,050 firm fixed price purchase order by the National Institutes of Health's National Human Genome Research Institute to deliver the Partek Genomics Suite. The five-year contract will provide the genomic analysis software to support NIH's efforts to advance genome research from August 2017 through August 2022. No subcontractors or set aside designations were identified. The award was issued under NIH's broader research programs focused on advancing the understanding...

<p>The National Human Genome Research Institute issued a purchase order to Partek, Incorporated on July 23, 2020, for Partek Flow Enterprise Edition with RNA-Seq and Single Cell Toolkits concurrent user license, with a ceiling value of $13,900 and a firm fixed price. The order carries no set-aside designation. Place of performance is Wildwood, Missouri. The ultimate completion date is September 30, 2020.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Biodiscovery, Inc. for $16,031.25 on December 18, 2017. Work is performed in Bethesda, Maryland. The order is for firm fixed price, with no small business set-aside. Ultimate completion is scheduled for December 29, 2017.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Golden Helix Inc. for $8,745.00 on December 19, 2017, with completion by January 2, 2019. No set-aside was applied. Work is performed in Bethesda, Maryland. The order uses firm fixed-price pricing for commercial bioinformatics software licenses and analytical tools to support genomic data analysis and research at the institute.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Chesapeake Mission Critical LLC valued at $13,871.00 on August 25, 2017, with a completion date of September 8, 2017. Work is performed in Bethesda, Maryland. The order is priced on a firm-fixed-price basis with no set-aside applied. Specific requirements are not detailed in the source material.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Eurofins Genomics LLC for $14,975.00 on December 13, 2016, with a firm fixed price for research studies. Place of performance is Bethesda, Maryland. The order was not set-aside and carries an ultimate completion date of January 11, 2021.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Golden Helix Inc. valued at $6,991.00 on June 22, 2017, for a firm fixed price.</p> <p>Place of performance is Bethesda, Maryland. The order ultimate completion date is August 1, 2018. No set-aside applies to this purchase order.</p>

Partek, Inc. was awarded a $3,670 purchase order by the National Institutes of Health's National Institute of Child Health and Human Development to provide Partek Genomics Suite software. The firm fixed price contract has a period of performance from September 5, 2014 through September 4, 2015. The software will support the research of James Kennison at the National Institutes of Health. No additional context was provided regarding subcontractors or the agency's programs. The Department of...

<p>The National Human Genome Research Institute awarded a purchase order to Golden Helix Inc. for $6,991.00 on May 23, 2018, with completion by August 1, 2019. No set-aside was used. Work is performed at Bethesda, Maryland. The order is for firm fixed-price procurement of genomic data analysis software or services supporting federal research operations.</p>